Inovio Pharmaceuticals Inc. Stock Slides 36.9%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. plummeted 36.9% to $0.66 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.8% to 25,122.18 and the Dow Jones Industrial Average rising 1.2% to 52,208.06.

The stock's fall snapped a two-day winning streak.

Inovio Pharmaceuticals Inc. closed 78.0% below its 52-week high of $2.98, which the company reached on September 9th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 3.7% to $255.82, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.95% to $24.91.

Trading volume totaled 33.2 million, compared to the 50-day average of 1.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 30, 2026 16:32 ET (20:32 GMT)